Q&A by Doctor Jeremie Calais on how PSMA PET imaging will change the landscape of prostate cancer detection and treatment. The new imaging technique can locate cancer lesions not only in the prostate, but can also track cancer that has spread to other parts of the body that is often missed by current standard-of-care imaging techniques.
"Access to PSMA PET will be widely available and this game-changer technology will ultimately become part of the routine staging of prostate cancer patients. Like doing a PSA test, I anticipate in a near future that physicians will routinely require a PSMA PET scan before making a treatment plan." Dr. Jeremie Calais.Other news & events
- News04.08.2026

Virtual Radiotheranostics Summit: Expanding Access to Targeted Cancer Care Across Africa
Read more - News29.07.2026

TerraPower Isotopes Collaborates with Oncidium Foundation to Donate Actinium-225, Expanding Cancer Treatment Access
Read more - News01.07.2026

Türkiye Introduces Reimbursement for Actinium-225 PSMA Therapy
Read more




